We Are Concerned about Ribavirin Exposure

Witek TJ , Schachter EN . Concern about ribavirin (letter). Respir Care 1988;33:506.

Harrison R , Bellows J. Health care worker exposure to ribavirin aerosol. Field Investigation FI-86-009. California Department of Health Services. Berkeley, California, 1988.

Rodriguez WJ , Bui RHD , Conner JD , . Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob Agents Chemother 1987;31:1143–1146.

Demers RR , Parker J , Frankel LR , Smith DW . Administration of ribavirin to neonatal and pediatric patients during mechanical ventilation. Respir Care 1986;31:1188–1196.

Johnson E. Cross-species extrapolations and the biologic basis for safety factor determinations in develop-mental toxicology. Regul Toxicol Pharmacol 1988;8:22–36.

Guidelines on the use of uncertainty factors. Federal Register 1985;50:46946, November 13.

Breese Hall C. Infections in older children and adults. In: Mandell GL , Douglas RG , eds. Principles and practice of infectious diseases. 2nd ed. New York: John Wiley & Sons, 1988.

American Academy of Pediatrics Committee on Infectious Diseases. Policy Statement: Ribavirin therapy of respiratory syncytial virus. AAP News December, 1986.